Low impact
Analysts have given Alnylam Pharmaceuticals an average price target of $436, suggesting a potential 45% increase.
Finnhub07/02, 05:53 PM
Related assets
Coming up for ALNY
Explore next
Latest ALNY news
Bloomberg07/31, 06:40 PM
ZeroHedge07/09, 07:13 PM